EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 151 filers reported holding EPIZYME INC in Q3 2020. The put-call ratio across all filers is 2.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,930,000 | -74.2% | 1,000,000 | -65.2% | 0.29% | -77.6% |
| Q2 2020 | $46,173,000 | +16.7% | 2,875,000 | +12.7% | 1.29% | -22.7% |
| Q1 2020 | $39,551,000 | -28.5% | 2,550,000 | +13.3% | 1.67% | -21.8% |
| Q4 2019 | $55,350,000 | +257.7% | 2,250,000 | +50.0% | 2.14% | +244.8% |
| Q3 2019 | $15,473,000 | -25.3% | 1,500,000 | -9.1% | 0.62% | -26.0% |
| Q2 2019 | $20,708,000 | -4.5% | 1,650,000 | -5.7% | 0.84% | -5.3% |
| Q1 2019 | $21,683,000 | – | 1,750,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |